Companies

Zydus Cadila gets USFDA nod for Acetazolamide ER capsules

BL Internet Desk | Updated on January 17, 2019 Published on January 17, 2019

These capsules are used to treat certain types of glaucoma and prevent altitude sickness

Zydus Cadila informed on Thursday that it has received the final approval from the USFDA to market Acetazolamide ER Capsules. It will be manufactured at the group’s formulations manufacturing facility at Moraiya, Ahmedabad.

Acetazolamide is a potent carbonic anhydrase inhibitor. Acetazolamide ER capsules are used to treat certain types of glaucoma (caused by increased ocular pressure) and to treat or prevent altitude sickness (acute mountain sickness).

The group now has 246 approvals and has so far filed over 330 ANDAs since the commencement of the filing process in FY 2003-04.

Published on January 17, 2019
This article is closed for comments.
Please Email the Editor